+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
From
Complement C5 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Complement C5 inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Disease Analysis: Osteoporosis - Product Thumbnail Image

Disease Analysis: Osteoporosis

  • Report
  • March 2021
  • 48 Pages
  • Global
From
Recombinant Proteins Market 2023-2027 - Product Thumbnail Image

Recombinant Proteins Market 2023-2027

  • Report
  • April 2023
  • 167 Pages
  • Global
From
Minimal Residual Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Minimal Residual Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Menopausal Hot Flashes Market 2021-2025 - Product Thumbnail Image

Menopausal Hot Flashes Market 2021-2025

  • Report
  • October 2021
  • 120 Pages
  • Global
From
Tardive Dyskinesia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Tardive Dyskinesia Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Loading Indicator